These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

168 related items for PubMed ID: 2581500

  • 21. 5-Azacytidine stimulates fetal hemoglobin synthesis in anemic baboons.
    DeSimone J, Heller P, Hall L, Zwiers D.
    Proc Natl Acad Sci U S A; 1982 Jul; 79(14):4428-31. PubMed ID: 6181507
    [Abstract] [Full Text] [Related]

  • 22. Progress toward increasing fetal hemoglobin production in man: experience with 5-azacytidine and hydroxyurea.
    Dover GJ, Charache S, Nora R, Boyer SH.
    Ann N Y Acad Sci; 1985 Jul; 445():218-24. PubMed ID: 2409873
    [No Abstract] [Full Text] [Related]

  • 23. 2-deoxy 5-azacytidine and fetal hemoglobin induction in sickle cell anemia.
    Koshy M, Dorn L, Bressler L, Molokie R, Lavelle D, Talischy N, Hoffman R, van Overveld W, DeSimone J.
    Blood; 2000 Oct 01; 96(7):2379-84. PubMed ID: 11001887
    [Abstract] [Full Text] [Related]

  • 24. Clinical management of gene expression.
    Benz EJ.
    N Engl J Med; 1982 Dec 09; 307(24):1515-6. PubMed ID: 6183587
    [No Abstract] [Full Text] [Related]

  • 25. 5-Azacytidine acts directly on both erythroid precursors and progenitors to increase production of fetal hemoglobin.
    Humphries RK, Dover G, Young NS, Moore JG, Charache S, Ley T, Nienhuis AW.
    J Clin Invest; 1985 Feb 09; 75(2):547-57. PubMed ID: 2579100
    [Abstract] [Full Text] [Related]

  • 26. [Pharmacological correction of genetic defects - azacytidine in the treatment of thalassemia].
    Kuratowska Z.
    Pol Tyg Lek; 1983 Jun 13; 38(24):713-5. PubMed ID: 6196764
    [No Abstract] [Full Text] [Related]

  • 27. A short-term trial of butyrate to stimulate fetal-globin-gene expression in the beta-globin disorders.
    Perrine SP, Ginder GD, Faller DV, Dover GH, Ikuta T, Witkowska HE, Cai SP, Vichinsky EP, Olivieri NF.
    N Engl J Med; 1993 Jan 14; 328(2):81-6. PubMed ID: 7677966
    [Abstract] [Full Text] [Related]

  • 28. Treatment of sickle cell anemia with 5-azacytidine results in increased fetal hemoglobin production and is associated with nonrandom hypomethylation of DNA around the gamma-delta-beta-globin gene complex.
    Charache S, Dover G, Smith K, Talbot CC, Moyer M, Boyer S.
    Proc Natl Acad Sci U S A; 1983 Aug 14; 80(15):4842-6. PubMed ID: 6192443
    [Abstract] [Full Text] [Related]

  • 29. [Fetal hemoglobin].
    Rokicka-Piotrowicz M.
    Postepy Hig Med Dosw; 1989 Aug 14; 43(5-6):475-97. PubMed ID: 2484927
    [Abstract] [Full Text] [Related]

  • 30. Fetal hemoglobin gene activation in a phase II study of 5,6-dihydro-5-azacytidine for bronchogenic carcinoma.
    Carr BI, Rahbar S, Doroshow JH, Blayney D, Goldberg D, Leong L, Asmeron Y.
    Cancer Res; 1987 Aug 01; 47(15):4199-201. PubMed ID: 2440559
    [Abstract] [Full Text] [Related]

  • 31. Disorders of the synthesis of human fetal hemoglobin.
    Manca L, Masala B.
    IUBMB Life; 2008 Feb 01; 60(2):94-111. PubMed ID: 18379999
    [Abstract] [Full Text] [Related]

  • 32. The role of fetal hemoglobin-enhancing agents in thalassemia.
    Lal A, Vichinsky E.
    Semin Hematol; 2004 Oct 01; 41(4 Suppl 6):17-22. PubMed ID: 15534853
    [Abstract] [Full Text] [Related]

  • 33. Delta beta thalassemia and hereditary persistence of fetal hemoglobin.
    Bollekens JA, Forget BG.
    Hematol Oncol Clin North Am; 1991 Jun 01; 5(3):399-422. PubMed ID: 1713909
    [Abstract] [Full Text] [Related]

  • 34. Concordant fetal hemoglobin response to hydroxyurea in siblings with sickle cell disease.
    Steinberg MH, Voskaridou E, Kutlar A, Loukopoulos D, Koshy M, Ballas SK, Castro O, Barton F.
    Am J Hematol; 2003 Feb 01; 72(2):121-6. PubMed ID: 12555216
    [Abstract] [Full Text] [Related]

  • 35. Altering gene expression with 5-azacytidine.
    Jones PA.
    Cell; 1985 Mar 01; 40(3):485-6. PubMed ID: 2578884
    [No Abstract] [Full Text] [Related]

  • 36. Chemotherapy to increase fetal hemoglobin in patients with sickle cell anemia.
    Platt OS.
    Am J Pediatr Hematol Oncol; 1985 Mar 01; 7(3):258-60. PubMed ID: 2416231
    [Abstract] [Full Text] [Related]

  • 37. Hydroxyurea in sickle cell disease--a study of clinico-pharmacological efficacy in the Indian haplotype.
    Italia K, Jain D, Gattani S, Jijina F, Nadkarni A, Sawant P, Nair S, Mohanty D, Ghosh K, Colah R.
    Blood Cells Mol Dis; 2009 Mar 01; 42(1):25-31. PubMed ID: 18954999
    [Abstract] [Full Text] [Related]

  • 38. Hydroxyurea increases hemoglobin F levels and improves the effectiveness of erythropoiesis in beta-thalassemia/hemoglobin E disease.
    Fucharoen S, Siritanaratkul N, Winichagoon P, Chowthaworn J, Siriboon W, Muangsup W, Chaicharoen S, Poolsup N, Chindavijak B, Pootrakul P, Piankijagum A, Schechter AN, Rodgers GP.
    Blood; 1996 Feb 01; 87(3):887-92. PubMed ID: 8562958
    [Abstract] [Full Text] [Related]

  • 39. Globin gene studies create a puzzle.
    Kolata G.
    Science; 1984 Feb 03; 223(4635):470-1. PubMed ID: 6197757
    [No Abstract] [Full Text] [Related]

  • 40. Increasing fetal hemoglobin in sickle cell disease: comparisons of 5-azacytidine (subcutaneous or oral) with hydroxyurea.
    Dover GJ, Charache S, Boyer SH.
    Trans Assoc Am Physicians; 1984 Feb 03; 97():140-5. PubMed ID: 6085527
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.